Siga Technologies SIGA
NASDAQ SIGA
$3.09 -0.11 (-3.44%)
As of: Sep 9, 2026 · 3:59 PM EDT

Siga Technologies (SIGA) Current Deferred Revenue (2016 - 2025)

Siga Technologies' (SIGA) quarterly Current Deferred Revenue came in at $10.2 million in Q4 2025, down 0.88% on a YoY basis from $10.3 million in Q4 2024, and little changed quarter-over-quarter from $10.2 million in Q3 2025.

Analysis

Siga Technologies (SIGA) Current Deferred Revenue (2016 - 2025) Analysis & Trends

Siga Technologies (SIGA) has reported Current Deferred Revenue for 10 consecutive years, with $10.2 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Current Deferred Revenue fell 0.88% year-over-year to $10.2 million; the trailing twelve-month figure through Dec 2025 stood at $10.2 million (down 0.88% YoY), and the FY2025 full-year result was $10.2 million, down 0.88% from the prior year.
  • Current Deferred Revenue was little changed at $10.2 million in Q4 2025 per SIGA's latest filing, from $10.2 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $21.9 million in Q3 2023 and bottomed at $793464.0 in Q1 2022.
  • Historically, Current Deferred Revenue has averaged $10.7 million across 5 years, with a median of $10.3 million in 2024.
  • The sharpest annual moves came in 2022 and 2023: Current Deferred Revenue tumbled 77.8% in 2022, then jumped 1226.02% in 2023.
  • Over 5 years, Current Deferred Revenue stood at $3.8 million in 2021, then surged by 180.2% to $10.5 million in 2022, then jumped by 97.07% to $20.8 million in 2023, then tumbled by 50.31% to $10.3 million in 2024, then fell by 0.88% to $10.2 million in 2025.
  • According to Business Quant data, Current Deferred Revenue over the past three periods registered $10.2 million, $10.2 million, and $10.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn
7 Revolution Medicines 43.79 Bn 43.79 Bn -
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn
10 Siga Technologies 220.19 Mn 65.22 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 10.24 Mn
Sep 30, 2025 10.24 Mn
Jun 30, 2025 10.24 Mn
Mar 31, 2025 10.33 Mn
Dec 31, 2024 10.33 Mn
Sep 30, 2024 13.73 Mn
Jun 30, 2024 13.73 Mn
Mar 31, 2024 20.79 Mn
Dec 31, 2023 20.79 Mn
Sep 30, 2023 21.90 Mn
Jun 30, 2023 11.37 Mn
Mar 31, 2023 10.52 Mn
Dec 31, 2022 10.55 Mn
Sep 30, 2022 10.13 Mn
Jun 30, 2022 7.04 Mn
Mar 31, 2022 793,464.00
Dec 31, 2021 3.76 Mn
Sep 30, 2021 3.59 Mn
Mar 31, 2021 3.57 Mn
Dec 31, 2020 3.28 Mn